Navigation Links
Farmers' Trans Fat Solution Efforts Preserve $700 Million Market
Date:2/17/2009

U.S. Soybean Growers' Foresight Credited with Industry's Strong Business Performance in Tough Economic Times

ST. LOUIS, Feb. 17 /PRNewswire/ -- With the U.S. economy in crisis, it's clear that strong domestic industries are essential, including food and agriculture. When the U.S. Food and Drug Administration (FDA) mandated trans fat appear on products' Nutrition Facts label, companies rushed to reformulate products to reduce or eliminate trans fat content. The blow could have been harsh for American jobs in the agriculture sector of the economy. However, the nation's soybean farmers are reaping the rewards of a long-term strategy, launched more than a decade ago by the United Soybean Board (USB), to develop new soybeans for healthier oils.

"The soybean industry created a soy-based trans fat solution (called low-linolenic soybean oil) that changed the face of the market, and protected American livelihoods while delivering a healthier future from farm to table," notes Chuck Myers, chairman of USB and a farmer in Lyons, Nebraska.

Myers explains, "Without it, our economic analysis shows that food companies would have reduced their need for soybean oil by 894 million pounds, soybean production would have dropped by 25 million bushels, and farmers would have earned 10.8 cents less per bushel. The analysis shows we prevented a cumulative lost income for U.S. soybean producers of $703.2 million."

The loss would have affected farmers, but also the seed sector, grain elevators, edible oil processors and refiners, food manufacturers and many other aspects of the food industry. Food companies needed to take the trans out, and thanks in part to USB's leadership and the foresight of the industry, most products today are labeled with zero grams of trans fat.

Richard Cristol, president of the National Association of Margarine Manufacturers adds, "Soybean oil is a natural plant oil that is very important to the margarine industry. While the margarine industry began removing trans fats from its products well before the FDA labeling requirement, USB has been and continues to be a valued partner in developing and promoting healthful oils for the food industry, especially with regard to the reduction and elimination of trans fats."

Myers describes milestones in USB's trans fat leadership over the years, including:

  1. "Understanding trans fats' effect on human health": USB was a significant contributor to early studies defining trans fats' effect on health, through research performed at the University of Massachusetts at Lowell and the U.S. Department of Agriculture.
  2. "Participating as a founding member of the Trans Fat Coalition": From 1994 to 2006, this group invested in new science, communicated findings to the public and providing timely information to government agencies, such as providing comments to the Dietary Guidelines Advisory Committees and responding to the FDA's requests for comment.
  3. "Mapping the soybean genome": As early as 1995, USB funded research to map the soybean genome and use advanced techniques to improve the bean's fatty acid profile to produce oil without partial hydrogenation (the process that creates trans fats).
  4. "Working with the whole value chain to identify desirable traits for the future": USB assembled experts from all aspects of the industry in 1998 to get input on solutions that would meet their needs. A platform called QUALISOY(TM) emerged to accelerate the development and commercialization of enhanced trait soybeans in the research pipeline.

As a result, food companies today can use low-linolenic soybean oil in light frying, sauces, rolls and pizza dough. Companies are also testing the next generation - increased-oleic soybean oil - for use in crackers, baked goods, margarines and shortenings. Beyond trans fat solutions, lowering saturated fat will support heart health and cholesterol reduction. USB's value chain analysis estimates high-oleic soybean oils to supply a $780 million average annual return in income throughout the industry. Mid-oleic, low-saturate oils will supply an estimated $1.495 billion average annual return over twenty years.

After first turning its attention to trans fat in the 1990s, USB continues to offer resources for a range of improvements from flavor and shelf stability to health benefits for the consumer. Food companies can take advantage of USB's online offerings and emailed newsletters for regular updates, visit USB at industry events such as tradeshows and conferences or even request USB deliver an oils expert to their corporate headquarters for an individualized consultation.

USB is comprised of 68 farmer-directors who oversee the investments of the soybean checkoff on behalf of all U.S. soybean farmers. For more information on soybean oil-based trans fat solutions, please visit www.soyconnection.com. For more information on the soybean checkoff, please visit www.unitedsoybean.org.


'/>"/>
SOURCE United Soybean Board
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Americas Egg Farmers Launch New Incredible Edible Egg(TM) Advertising Campaign Focusing on Body And Mind
2. Philippine Farmers Bank Turns to Misys to Underpin its Consumer Lending Business
3. Farmers Insurance Group(R) Raises More Than $3.2 Million in a Single Day for the March of Dimes
4. Organic Farming Research Foundation Applauds Farm Bill Victories for Organic Farmers and Ranchers
5. Farmers and ranchers pay top dollar for inadequate health insurance protection
6. Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
7. HIMSS Electronic Health Record Association Supports Economic Stimulus Package as Key to Healthcare Transformation
8. Transporter could help breast cancer cells commit suicide
9. New Website Coming Soon for Electronic Medical Transcription Company
10. Subway Accident Victim Wins $3.595 Million Verdict Against The New York City Transit Authority
11. IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Calif. (PRWEB) , ... December 02, 2016 , ... On ... at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who ... neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Advanced Inc., a ... has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, ... Inc. , Jason brings extensive financial and operational leadership experience to Advanced Inc. ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to change Medicare ... Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from ... (Part D) need to make changes during this period order for their new policy ...
(Date:12/2/2016)... York, NY (PRWEB) , ... December 02, 2016 ... ... featuring an inspirational interview of two ostomy patients, standing as living proof that ... people suffer from digestive diseases and issues that spike around the holidays. This ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to announce ... covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients ... life 6 years in the last 3 decades,” says Dr. Valentine Fuster, a ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... On Thursday, the NASDAQ Composite and ... the Dow Jones Industrial Average managed to stay in green. ... which prompted Stock-callers this morning to look at the performances ... NUVA ), Smith & Nephew PLC (NYSE: SNN ... Cesca Therapeutics Inc. (NASDAQ: KOOL ). You can ...
(Date:12/2/2016)... 2016 The concept of rare diseases and the ... this sector has been taking shape in Europe ... aspects and initiatives related to orphan medicinal products have been ... of member states individually. Many member states in the EU ... of orphan medicinal products, the result of which took the ...
Breaking Medicine Technology: